Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
02 2019
Historique:
received: 06 11 2018
accepted: 07 11 2018
pubmed: 21 11 2018
medline: 28 1 2020
entrez: 21 11 2018
Statut: epublish

Résumé

We investigated the epidemiology and resistance mechanisms of ampicillin-sulbactam-nonsusceptible

Identifiants

pubmed: 30455244
pii: AAC.02366-18
doi: 10.1128/AAC.02366-18
pmc: PMC6355572
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ampicillin 7C782967RD
beta-Lactamases EC 3.5.2.6
beta-lactamase TEM-1 EC 3.5.2.6
Sulbactam S4TF6I2330

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Clin Microbiol Rev. 2014 Jul;27(3):543-74
pubmed: 24982321
J Antimicrob Chemother. 2010 Mar;65(3):490-5
pubmed: 20071363
J Infect Chemother. 2017 Jun;23(6):339-348
pubmed: 28391954
Diagn Microbiol Infect Dis. 2013 Aug;76(4):532-3
pubmed: 23726651
J Clin Microbiol. 2011 Aug;49(8):2798-803
pubmed: 21632895
J Antimicrob Chemother. 2005 Jul;56(1):122-7
pubmed: 15890715
J Antimicrob Chemother. 1991 May;27(5):569-75
pubmed: 1653204
J Clin Microbiol. 1986 Sep;24(3):330-2
pubmed: 3489731
J Antimicrob Chemother. 2008 Mar;61(3):498-503
pubmed: 18250231
Antimicrob Agents Chemother. 2009 Jul;53(7):2733-9
pubmed: 19398649
FEMS Microbiol Lett. 1999 Jul 1;176(1):11-5
pubmed: 10418127
Emerg Infect Dis. 2016 Nov;22(11):1900-1907
pubmed: 27767006
J Clin Microbiol. 2002 Jun;40(6):2153-62
pubmed: 12037080
Rev Argent Microbiol. 2014 Jul-Sep;46(3):210-7
pubmed: 25444130
J Infect Dis. 2013 Mar 15;207(6):919-28
pubmed: 23288927
Int J Antimicrob Agents. 2016 Apr;47(4):328-34
pubmed: 27005459
Appl Environ Microbiol. 2007 Mar;73(6):1976-83
pubmed: 17277222
J Antimicrob Chemother. 2010 Dec;65(12):2518-29
pubmed: 20935300
Environ Microbiol Rep. 2013 Feb;5(1):58-65
pubmed: 23757131
J Antimicrob Chemother. 2017 Apr 1;72(4):1040-1049
pubmed: 28077674
J Antimicrob Chemother. 2011 Apr;66(4):745-51
pubmed: 21393132
Antimicrob Agents Chemother. 2004 Jan;48(1):1-14
pubmed: 14693512
Clin Microbiol Rev. 2010 Jan;23(1):160-201
pubmed: 20065329
Antimicrob Agents Chemother. 1994 Mar;38(3):494-8
pubmed: 8203843
J Med Microbiol. 2005 Dec;54(Pt 12):1183-7
pubmed: 16278432
Antimicrob Agents Chemother. 2012 Jul;56(7):3576-81
pubmed: 22491692
J Antimicrob Chemother. 2009 Jan;63(1):67-71
pubmed: 18931389
Antimicrob Agents Chemother. 2011 Feb;55(2):495-501
pubmed: 21135189
Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1417-25
pubmed: 20700614
Appl Environ Microbiol. 2012 Mar;78(5):1353-60
pubmed: 22226951
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5694-9
pubmed: 24706808
Antimicrob Agents Chemother. 2002 Dec;46(12):4035-7
pubmed: 12435720
J Antimicrob Chemother. 2002 Jul;50(1):11-8
pubmed: 12096001
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):E2629-34
pubmed: 23798411
Antimicrob Agents Chemother. 1985 Apr;27(4):555-60
pubmed: 3873900
Antimicrob Agents Chemother. 2002 Oct;46(10):3156-63
pubmed: 12234838
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
J Clin Microbiol. 2000 Jan;38(1):40-3
pubmed: 10618060
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28584160

Auteurs

Taro Noguchi (T)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yasufumi Matsumura (Y)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan yazblood@kuhp.kyoto-u.ac.jp.

Toru Kanahashi (T)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Michio Tanaka (M)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Yasuhiro Tsuchido (Y)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Takuro Matsumura (T)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Satoshi Nakano (S)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Masaki Yamamoto (M)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Miki Nagao (M)

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Satoshi Ichiyama (S)

Shiga General Hospital, Shiga, Japan.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
1.00
Humans Cross-Sectional Studies Telemedicine Japan Surveys and Questionnaires

Classifications MeSH